Daybue acadia who is the originator?

Who originally created Daybue (acadia)?

Daybue (trofinetide) is an investigational and then approved treatment for Rett syndrome developed by Acadia Pharmaceuticals. Acadia Pharmaceuticals is the company behind the drug’s development and commercialization. [1]

What does “originator” usually mean for a drug like Daybue?

In drug discussions, “originator” typically refers to the original developer/brand owner of the first marketed product. For Daybue, that originator is Acadia Pharmaceuticals. [1]

Is Daybue the work of an individual person, or a company?

For most prescription medicines, the originator is the sponsoring company that develops the therapy through clinical trials and regulatory review, rather than a single named individual. In this case, Daybue’s originator is tied to Acadia Pharmaceuticals. [1]

Related: what is Daybue used for?

Daybue (trofinetide) is used for Rett syndrome. [1]

Sources:
[1] https://www.acadia.com/our-medicines/daybue/